予防可能な慢性疾患の症例の増加、医療費削減の必要性、ベンチャーキャピタルの成長、デジタルの利点により、デジタル治療市場は予測期間中26.1%のCAGRで成長し2032年までに472億ドルに達すると予想されます。さらに、デジタル療法は疎外された人々のケアへのアクセスを増やし、医療専門家が慢性疾患をより効果的に管理できるようにする可能性があります。これらの要因が、予測期間中、世界のデジタル治療市場を促進するでしょう。
目次
1 Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Digital Therapeutics Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 Market Characteristics
3.1. Market Definition
3.2. Digital Therapeutics Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 Digital Therapeutics Market - Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 Macroeconomic Indicators
6 Recent Developments
7 Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 Market Analysis
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9 Digital Therapeutics Market
9.1. Overview
9.2. Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10 Digital Therapeutics Market Size & Forecast 2022A-2032F
10.1. Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Type
10.3.1.1. Devices
10.3.1.1.1. By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.2. Software & Services
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2. Market Share (%) 2022-2032F
10.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2. By Application
10.3.2.1. Diabetes
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2. Market Share (%) 2022-2032F
10.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.2. Obesity
10.3.2.2.1. By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3. CVD
10.3.2.3.1. By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.4. Respiratory Diseases
10.3.2.4.1. By Value (USD Million) 2022-2032F
10.3.2.4.2. Market Share (%) 2022-2032F
10.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.5. Smoking Cessation
10.3.2.5.1. By Value (USD Million) 2022-2032F
10.3.2.5.2. Market Share (%) 2022-2032F
10.3.2.5.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.6. CNS Diseases
10.3.2.6.1. By Value (USD Million) 2022-2032F
10.3.2.6.2. Market Share (%) 2022-2032F
10.3.2.6.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.7. Others
10.3.2.7.1. By Value (USD Million) 2022-2032F
10.3.2.7.2. Market Share (%) 2022-2032F
10.3.2.7.3. Y-o-Y Growth (%) 2022-2032F
10.3.3. By End User
10.3.3.1. Patients
10.3.3.1.1. By Value (USD Million) 2022-2032F
10.3.3.1.2. Market Share (%) 2022-2032F
10.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.2. Providers
10.3.3.2.1. By Value (USD Million) 2022-2032F
10.3.3.2.2. Market Share (%) 2022-2032F
10.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.3. Payers
10.3.3.3.1. By Value (USD Million) 2022-2032F
10.3.3.3.2. Market Share (%) 2022-2032F
10.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.4. Employers
10.3.3.4.1. By Value (USD Million) 2022-2032F
10.3.3.4.2. Market Share (%) 2022-2032F
10.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.5. Others
10.3.3.5.1. By Value (USD Million) 2022-2032F
10.3.3.5.2. Market Share (%) 2022-2032F
10.3.3.5.3. Y-o-Y Growth (%) 2022-2032F
11 North America Digital Therapeutics Market Size & Forecast 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Type
11.3.2. By Application
11.3.3. By End User
11.4. Country
11.4.1. United States
11.4.2. Canada
12 Europe Digital Therapeutics Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Type
12.3.2. By Application
12.3.3. By End User
12.4. Country
12.4.1. Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13 Asia Digital Therapeutics Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Type
13.3.2. By Application
13.3.3. By End User
13.4. Country
13.4.1. India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14 Middle East and Africa Digital Therapeutics Market Size & Forecast 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Type
14.3.2. By Application
14.3.3. By End User
14.4. Country
14.4.1. Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15 Latin America Digital Therapeutics Market Size & Forecast 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Type
15.3.2. By Application
15.3.3. By End User
15.4. Country
15.4.1. Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16 Competitive Landscape
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17 Company Profiles
17.1. AmerisourceBergen
17.1.1. Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4. Company Assessment
17.1.4.1. Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. ResMed
17.3. Teladoc Health Inc.
17.4. Fitbit LLC
17.5. Omada Health Inc.
17.6. Pear Therapeutics Inc.
17.7. GAIA AG
17.8. BigHealth
17.9. Welldoc Inc.
17.10. DarioHealth Corp.
17.11. Akili Interactive Labs Inc.
17.12. HYGIEIA
17.13. Canary Health
17.14. 2Morrow Inc.
17.15. Limbix Health Inc.
17.16. Other Prominent Players
18 Appendix
19 Consultant Recommendation
